Upload
hiranger
View
216
Download
0
Embed Size (px)
Citation preview
7/25/2019 fat_embolism.pdf
1/47
Fat Embolism Syndrome
Dr. Alex Rabinovich
7/25/2019 fat_embolism.pdf
2/47
Introduction
Zenker (Pathologist) first identified fat
embolism syndrome (FES) at autopsy in1862.
von Bergmann was the first physician toidentify FES clinically in 1873.
Initial clinical description was respiratory
and neurological manifestations with
petechial hemorrhages.
7/25/2019 fat_embolism.pdf
3/47
Introduction
Most commonly associated with LONG BONE
(Femur, Tibia, Humerus, ), PELVIC andSPINAL #s
More frequent in CLOSED > OPEN #s
Younger pts (more bone marrow) > Older Pts
A single long bone # has 1-5% chance of
developing FES, this directly correlates with thenumber of long bone #s
FES has been reported as high as 33% in
bilateral femoral fractures.
7/25/2019 fat_embolism.pdf
4/47
Introduction
7/25/2019 fat_embolism.pdf
5/47
Pathophysiology
2 Theories
Mechanical vs. Biochemical Mechanical
Fat globules from disrupted bone marrow or adipose
tissue are forced into torn venules in areas of trauma.
Biochemical
Hormonal changes caused by trauma and/or sepsisinduce systemic release of free fatty acids (FFA) as
chylomicrons which cause the systemic FES.
7/25/2019 fat_embolism.pdf
6/47
7/25/2019 fat_embolism.pdf
7/47
Pathophysiology
Mechanical
This theory is supported by research onOrthopaedic long bone (IM reaming) andspinal surgeries which cause fat globules to
enter the blood circulation when vigorousreaming/fixation is done.
Increased Pressure + Volume
Extravasation Measuring fat globules pre and post reaming
shows significant difference in concentration.
7/25/2019 fat_embolism.pdf
8/47
7/25/2019 fat_embolism.pdf
9/47
Pathophysiology
Mechanical
But what makes this clinically significant? Fat droplets are deposited in the pulmonary capillary
beds and travel through arteriovenous shunts to the
brain. Systems affected include LUNG, BRAIN andCIRCULATION.
Microvascular lodging of droplets produces local
ischemia and inflammation, with concomitant releaseof inflammatory mediators, platelet aggregation, and
vasoactive amines.
7/25/2019 fat_embolism.pdf
10/47
Pathophysiology
Biochemical
FES is dependent upon degradation of the embolizedfat into free fatty acids.
Neutral fat does not cause an acute lung injury, it is
hydrolyzed over the course of hours to severalproducts, including FFA, which cause ARDS in animal
models.
CRP (acute phase reactant), which is elevated intrauma patients, appears to be responsible in lipid
agglutination (FES) for both traumatic and non-
traumatic FES.
7/25/2019 fat_embolism.pdf
11/47
Pathophysiology
Biochemical
The process of Neutral fat cells -> FFA ->Agglutination with CRP may explain the time
sequence of clinical findings in FES.
Onset of symptoms may coincide with
Agglutination.
This theory is animal model based andcircumstantial at best.
7/25/2019 fat_embolism.pdf
12/47
Clinical
Diagnosis is made clinically NOT
chemically. It does not matter how muchfat globules are in your circulation, it justmatters if you have their side effects.
FES typically manifests 24 to 72 hoursafter the initial insult. Rarely 72 hrs.
Classic triad: Hypoxemia; Neurologicabnormalities; and a Petechial Rash
7/25/2019 fat_embolism.pdf
13/47
Clinical
SOB, Inc RR, Hypoxemia are early findings.50% of pts with symptoms will need ventilationsupport. Respiratory dysfunction is major causeof mortality, which is about 10-20%.
Neurologic symptoms usually develop after lunginjury, and include: Confusion, altered LOC,Headaches, +/- Seizures, +/- Strokes with FocalDeficits.
Petechial rash is usually a late finding(frequency of 20-50% of pts). Head, neck,
anterior thorax, subconjunctiva, and axillae aremost common regions.
7/25/2019 fat_embolism.pdf
14/47
Clinical Petechiae result from the occlusion of dermal
capillaries by fat globules, leading toextravasation of erythrocytes.
No abnormalities of platelet function have beendocumented.
The rash resolves in five to seven days. Other Findings
Scotomata (Purtscher's retinopathy)
Lipiduria Fevel
Coagulation Abnormalities (DIC like)
Myocardial Depression
7/25/2019 fat_embolism.pdf
15/47
7/25/2019 fat_embolism.pdf
16/47
7/25/2019 fat_embolism.pdf
17/47
7/25/2019 fat_embolism.pdf
18/47
Diagnosis FES is clinical diagnosis
CXR (n) mostly. Some have patchy
consolidations at periphery or bases due toalveolar hemorrhages, but not sensitive norspecific (snow storm pattern).
Ventilation/perfusion scans may demonstrate a
mottled pattern of subsegmental perfusiondefects with a normal ventilatory pattern.
Focal areas of ground glass opacification with
interloblar septal thickening are generally seenon chest CT
MRI of the brain may reveal high intensity T2
signal, which correlates with the degree ofclinical neurologic impairment
7/25/2019 fat_embolism.pdf
19/47
Diagnosis Common misconception that the presence of fat
globules, either in sputum, urine, or a wedgedPA catheter, is necessary to confirm the
diagnosis of FES In 50% of fracture patients, fat globules was
demonstrated in the serum, without symptoms of
FES.
HOWEVER
Growing literature on the use of bronchoscopywith bronchoalveolar lavage to detect fatdroplets in alveolar macrophages as a means to
diagnose fat embolism. Sensitivity and specificityare unknown, being studied in Trauma patients.
7/25/2019 fat_embolism.pdf
20/47
Diagnosis Classic Gurds criteria 1 major criteria and at least 4 minor criteria
Major Criteria
PaO2 < 60mmHg &
FiO2 >40%
Altered mentation Petechial rash
Minor Criteria
Temp > 38.5 0C
HR > 120/min
PLTs < 150 X 109/L Retinal fat emboli
Oliguria/anuria
Fat globules in urine
HCT not attributed to
blood loss or IVF dilution
Fat macroglobulemia
7/25/2019 fat_embolism.pdf
21/47
Treatment ATLS protocol
High clinical suspicion during 3rd survey
1. Early immobilization of fracture and early
definitive reduction (open or closed).
2. Maintain intravascular volume tomaintain cardiovascular stability
(hypovolemic shock resuscitation), mayuse colloids (albumin) as it can expand
fluid and bind FFA.
3. Mechanical ventilation with PEEP
7/25/2019 fat_embolism.pdf
22/47
Treatment
4. IV Ethanol has been used in Russia,
Europe and some American centres todecrease rate of FES.J Bone Joint Surg Am. 1977 Oct;59(7):878-80
A raised level of alcohol in the bloodwas associated with a lower incidence offat embolism all other variables
controlled.
Other studiesCan J Surg. 1970 Jan;13(1):41-9Br Med J. 1978 May 13;1(6122):1232-4
7/25/2019 fat_embolism.pdf
23/47
Treatment5. Corticosteroids (controversial) Surg Gynecol Obstet. 1978 Sep;147(3):358-62
Ann Intern Med. 1983 Oct;99(4):438-43
J Trauma. 1987 Oct;27(10):1173-6
J Bone Joint Surg [Br] 1987 Jan;69(1):128-31
Methylprednisolone is the study drug
Randomized double blind studies Specific to fractures and all other variables
controlled. RCTs with control drugs.
Differences was dosing and timing of drugadmin.
Major S/E looked at: GI Bleeds, Infections,Delayed healing, Cortisol issues, and CVSstability (cardiac mostly), Mortality
7/25/2019 fat_embolism.pdf
24/47
Treatment
5. Corticosteroids
Other doses: 1.5 mg/kg q8h X 48 hrs
Statistical Significance in reduction of clinical diagnosed FES
No major complications were noted
Potential for complications is the major concern (bleeds, infection,
cardiac compromise)
Key is to initiate treatment early and for a short period of time Be cautious of the S/E
12 doses
7/25/2019 fat_embolism.pdf
25/47
Treatment
The overall outcomes of FES with respect toisolated long bone, pelvis and spine fractures isgood with standard immobilization and reductionof fracture, fluid resuscitation and ventilatorsupport as needed.
Steroids and Ethanol treatments can be adjunctsto treatment, but most be started early.Recommended to start with low dose and for aperiod of 24-48 hours.
No evidence on Steroids or Ethanol Tx onceFES is diagnosed. This is only for Prophylaxis
7/25/2019 fat_embolism.pdf
26/47
Almost Over
Now that you have learned the basics of
FES. Its time for your final exam
7/25/2019 fat_embolism.pdf
27/47
Questions
What percentage of people with skeletal
trauma would normally develop fat emboli, andwhat percentage of these would then develop
the Fat Embolism Syndrome?
1. 30% and 12%
2. 50% and 10%3. 70% and 1%
4. 90% and 5%
7/25/2019 fat_embolism.pdf
28/47
Questions
What percentage of people with skeletal
trauma would normally develop fat emboli, andwhat percentage of these would then develop
the Fat Embolism Syndrome?
1. 30% and 12%
2. 50% and 10%
3. 70% and 1%
4. 90% and 5%
7/25/2019 fat_embolism.pdf
29/47
Questions
How does fat emboli enter the systemic
circulation (arterial vs. venous)?
7/25/2019 fat_embolism.pdf
30/47
Questions
How does fat emboli enter the systemic
circulation (arterial vs. venous)?
Patent Foramen Ovale
7/25/2019 fat_embolism.pdf
31/47
What percentage of the generalpopulation are considered to have apatent foramen ovale?
5%
15%
25%
40%
Questions
7/25/2019 fat_embolism.pdf
32/47
What percentage of the generalpopulation are considered to have apatent foramen ovale?
5%
15%
25%
40%
Questions
7/25/2019 fat_embolism.pdf
33/47
Questions
A biochemical theory suggests that a chemical eventduring trauma, or during the activation of the stress
response, affects the solubility of circulating lipidscausing them to coalesce and form systemic emboli.These emboli travel to lungs, brain and skin to give theFES triad of signs.
There are some very unusual causes of FES in the non-trauma patients, including the strikingly unusual:liposuction, chemotherapy, renal transplant.
1. True
2. False
7/25/2019 fat_embolism.pdf
34/47
Questions
A biochemical theory suggests that a chemical eventduring trauma, or during the activation of the stress
response, affects the solubility of circulating lipidscausing them to coalesce and form systemic emboli.These emboli travel to lungs, brain and skin to give theFES triad of signs.
There are some very unusual causes of FES in the non-trauma patients, including the strikingly unusual:liposuction, chemotherapy, renal transplant.
1. True
2. False
7/25/2019 fat_embolism.pdf
35/47
Questions The pulmonary signs are usually noted first and include
tachypnoeia, dyspnoea and cyanosis. These signsresult from the embolic fat being hydrolised by lung
lipase with the release of lung-toxic FFA. These FFAsinduce an acute lung injury and subsequent ARDS.
This process accounts for the time period betweeninjury and onset of clinical signs of FES. Time period isusually:
1. 6 to 12 hours
2. 12 to 24 hours
3. 24 to 72 hours
4. 72 to 84 hours
7/25/2019 fat_embolism.pdf
36/47
Questions The pulmonary signs are usually noted first and include
tachypnoeia, dyspnoea and cyanosis. These signsresult from the embolic fat being hydrolised by lung
lipase with the release of lung-toxic FFA. These FFAsinduce an acute lung injury and subsequent ARDS.
This process accounts for the time period betweeninjury and onset of clinical signs of FES. Time period isusually:
1. 6 to 12 hours
2. 12 to 24 hours
3. 24 to 72 hours
4. 72 to 84 hours
7/25/2019 fat_embolism.pdf
37/47
Questions
The cutaneous signs are usually seen within 72hours. On a critically ill patient they may go
unnoticed, thereby losing the chance forconfirmation of diagnosis.
The rash is usually seen on:
1. Thighs / Calves / Ankles
2. Clustered around the fracture site3. Chest / Axilla / Conjunctiva
4. Back of the head and knees
7/25/2019 fat_embolism.pdf
38/47
Questions
The cutaneous signs are usually seen within 72hours. On a critically ill patient they may go
unnoticed, thereby losing the chance forconfirmation of diagnosis.
The rash is usually seen on:
1. Thighs / Calves / Ankles
2. Clustered around the fracture site3. Chest / Axilla / Conjunctiva
4. Back of the head and knees
Q
7/25/2019 fat_embolism.pdf
39/47
Questions
Cerebral signs are non-specific, very rarely focal:headache, irritability and delirium. Severe cases may
show coma and convulsions. These signs are producedby embolism of fat through a patent foramen ovale andsubsequent microvascular occlusion of the braincirculation by fat.
Embolic fat can produce the necessary right heartpressures to open a patent foramen ovale but what isanother causative factor?
1. Increased cardiac pressures from ventilation2. Pneumothorax or haemothorax
3. Poor positioning on the OR table
4. Pressure exerted on the chest by OR equipment
Q ti
7/25/2019 fat_embolism.pdf
40/47
Questions
Cerebral signs are non-specific, very rarely focal:headache, irritability and delirium. Severe cases may
show coma and convulsions. These signs are producedby embolism of fat through a patent foramen ovale andsubsequent microvascular occlusion of the braincirculation by fat.
Embolic fat can produce the necessary right heartpressures to open a patent foramen ovale but what isanother causative factor?
1. Increased cardiac pressures from ventilation2. Pneumothorax or haemothorax
3. Poor positioning on the OR table
4. Pressure exerted on the chest by OR equipment
Q ti
7/25/2019 fat_embolism.pdf
41/47
Questions Diagnosis is always made on clinical grounds, there is no specific"test" for FES. Various sets of criteria exist to make the diagnosis
more accurate, such as those of Gurd & Wilson or those ofVedrienne, Guillaume and Gagnieu.
Management is then supportive as there is no specific treatment ofthe FES. Guidelines for the management of FES would include:
1. Prompt immobilisation of the fracture / delayed internal fixation ofthe fracture / early use of steroids / early use of Heparin
2. Prompt immobilisation of the fracture / early internal fixation of thefracture / prompt treatment of hypoxia / maintenance of cardiacoutput
3. Prompt immobilisation of fracture / intraoperative surgicalembolectomy / early use of IV Ethanol / daily low dose Aspirin
4. Prompt immobilisation of the fracture / avoidance of intramedullarynails / early use of steroids / mandatory use of calf compressors
Q ti
7/25/2019 fat_embolism.pdf
42/47
Questions Diagnosis is always made on clinical grounds, there is no specific"test" for FES. Various sets of criteria exist to make the diagnosis
more accurate, such as those of Gurd & Wilson or those ofVedrienne, Guillaume and Gagnieu.
Management is then supportive as there is no specific treatment ofthe FES. Guidelines for the management of FES would include:
1. Prompt immobilisation of the fracture / delayed internal fixation ofthe fracture / early use of steroids / early use of Heparin
2. Prompt immobilisation of the fracture / early internal fixation ofthe fracture / prompt treatment of hypoxia / maintenance ofcardiac output
3. Prompt immobilisation of fracture / intraoperative surgicalembolectomy / early use of IV Ethanol / daily low dose Aspirin
4. Prompt immobilisation of the fracture / avoidance of intramedullarynails / early use of steroids / mandatory use of calf compressors
Q ti
7/25/2019 fat_embolism.pdf
43/47
Questions
A Pulmonary Artery Catheter is often inserted tofacilitate the use of inotropic agents and fluids in a
critically ill patient with FES. Bearing in mind that therewill be widespread microvascular occlusion with fat inthe pulmonary vasculature what would be the mosttypical finding?
1. A high Systemic Vascular Resistance (SVR)
2. A low Systemic Vascular Resistance (SVR)
3. A high Pulmonary Vascular Resistance (PVR)4. A low Pulmonary Vascular Resistance (PVR)
Q ti
7/25/2019 fat_embolism.pdf
44/47
Questions
A Pulmonary Artery Catheter is often inserted tofacilitate the use of inotropic agents and fluids in a
critically ill patient with FES. Bearing in mind that therewill be widespread microvascular occlusion with fat inthe pulmonary vasculature what would be the mosttypical finding?
1. A high Systemic Vascular Resistance (SVR)
2. A low Systemic Vascular Resistance (SVR)
3. A high Pulmonary Vascular Resistance (PVR)4. A low Pulmonary Vascular Resistance (PVR)
Q ti
7/25/2019 fat_embolism.pdf
45/47
Questions
A patient who does not develop a
petechial rash by day 2 or 3 on his or herchest, anterior axillary folds or
conjunctiva does not have either Fat
Embolism or Fat Embolism Syndrome.
1. True2. False
Questions
7/25/2019 fat_embolism.pdf
46/47
Questions
A patient who does not develop a
petechial rash by day 2 or 3 on his or herchest, anterior axillary folds or
conjunctiva does not have either Fat
Embolism or Fat Embolism Syndrome.
1. True2. False
The END
7/25/2019 fat_embolism.pdf
47/47
The END
Thank you
References
1. UpToDate website2. eMedicine website